Neurodegenerative disease Archives

In Depth 2 Apr 2025

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer’s disease treatments.

April 2, 2025 - 10 minutesmins - By Jules Adam

Podcast 21 Mar 2025

Are mitochondrial therapeutics about to go mainstream?

Listen to our talk with Klaus Dugi, CEO of Vandria, about mitochondrial therapeutics and longevity

March 21, 2025

Best in Biotech 25 Feb 2025

Seven biotech spinouts to watch out for in 2025

Here are seven biotech spinouts to keep an eye out for this year that specialize in a number of therapeutic areas.

February 25, 2025 - 9 minutesmins - By Roohi Mariam Peter

Libra Therapeutics, the virtual biotech company using data to boost CNS drug development

How a virtual company leveraged data to accelerate drug development for neurodegenerative diseases

Find out how the virtual biotech company Libra Therapeutics leveraged data to accelerate drug development for neurodegenerative diseases.

February 25, 2025 - 9 minutesmins - By External Contributor

monoclonal antibodies for Alzheimers disease

In Depth 10 Feb 2025

Monoclonal antibodies: are they the key to treating Alzheimer’s disease?

A major stride in treating Alzheimer’s disease has been the development of monoclonal antibodies.

February 10, 2025 - 9 minutesmins - By Roohi Mariam Peter

Best in Biotech 22 Jan 2025

Curing ALS? Sixteen companies developing new treatments in 2025

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in 2025.

January 22, 2025 - 18 minutesmins - By Jules Adam

Best in Biotech 26 Nov 2024

Seven miRNA-focused companies pioneering new therapies in 2024

Delve into the field of miRNA with seven companies with miRNA-focused candidates in the pipeline in 2024, from oncology to neurodegeneration.

November 26, 2024 - 9 minutesmins - By Jules Adam

In Depth 21 Nov 2024

Huntington’s disease: a therapeutic field on a bumpy ride

For years, biotechs have been trying to develop medicines to cure the disease but much to no avail. Now, as clinical studies advance, there is hope.

November 21, 2024 - 9 minutesmins - By Roohi Mariam Peter

20S proteasome activation: Berlin biotech Booster Therapeutics secures $15 million for innovative therapies to tackle neurodegenerative diseases

News and Trends 15 Oct 2024

Booster launches to treat neurodegenerative diseases with proteasome activation

Discover Booster Therapeutics’ novel proteasome activation approach to neurodegenerative diseases as it launches with $15 million.

October 15, 2024 - 6 minutesmins - By Jules Adam

In Depth 26 Sep 2024

The radiopharmaceutical revolution: From diagnosis to treatment, oncology and beyond

Delve into the world of radiopharmaceuticals: explore their mechanisms, promising candidates, and the key players driving innovation.

September 26, 2024 - 14 minutesmins - By Jules Adam

In Depth 19 Sep 2024

Mitochondrial disease treatments: is a breakthrough on the horizon?

Mitochondrial dysfunction is linked to many diseases. Discover how biotechs are developing mitochondrial disease treatments to address these diseases.

September 19, 2024 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 1 Aug 2024

European regulators reject Alzheimer’s drug Leqembi: is it downhill from here?

European regulators have now refused to market the Alzheimer’s drug Leqembi after it was approved by the FDA last year.

August 1, 2024 - 6 minutesmins - By Roohi Mariam Peter

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Neurodegenerative disease

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Are mitochondrial therapeutics about to go mainstream?

Seven biotech spinouts to watch out for in 2025

How a virtual company leveraged data to accelerate drug development for neurodegenerative diseases

Monoclonal antibodies: are they the key to treating Alzheimer’s disease?

Curing ALS? Sixteen companies developing new treatments in 2025

Seven miRNA-focused companies pioneering new therapies in 2024

Huntington’s disease: a therapeutic field on a bumpy ride

Booster launches to treat neurodegenerative diseases with proteasome activation

The radiopharmaceutical revolution: From diagnosis to treatment, oncology and beyond

Mitochondrial disease treatments: is a breakthrough on the horizon?

European regulators reject Alzheimer’s drug Leqembi: is it downhill from here?

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!